Alkermes (NASDAQ: ALKS)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Alkermes (NASDAQ: ALKS) through any online brokerage.
The latest price target for Alkermes (NASDAQ: ALKS) was reported by SVB Leerink on Thursday, April 28, 2022. The analyst firm set a price target for 27.00 expecting ALKS to fall to within 12 months (a possible -9.06% downside). 14 analyst firms have reported ratings in the last year.
The stock price for Alkermes (NASDAQ: ALKS) is $29.69 last updated May 17, 2022, 8:00 PM UTC.
There are no upcoming dividends for Alkermes.
Alkermes’s Q2 earnings are confirmed for Wednesday, July 27, 2022.
There is no upcoming split for Alkermes.
Alkermes is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.